{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:19:44Z","timestamp":1784650784751,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006280","name":"Urology Care Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006280","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002553"],"award-info":[{"award-number":["UL1TR002553"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1-K08CA267062-01A1"],"award-info":[{"award-number":["1-K08CA267062-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Health Policy OPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.hpopen.2026.100163","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:59:36Z","timestamp":1769443176000},"page":"100163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United States"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3868-6920","authenticated-orcid":false,"given":"Deborah R.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7887-0204","authenticated-orcid":false,"given":"Charles D.","family":"Scales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Kate","family":"Bundorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpopen.2026.100163_b0005","unstructured":"CMS.gov. Transparency in Coverage. 2023."},{"key":"10.1016\/j.hpopen.2026.100163_b0010","unstructured":"L. BSRCG. The Commonwealth Fund. 2018. [cited 2023 10\/10\/2023]. Available from: https:\/\/www.commonwealthfund.org\/blog\/2018\/trump-administrations-prescription-drug-blueprint-tackle-high-us-prices-will-need-more#:\u223c:text=Titled%20%E2%80%9CAmerican%20Patients%20First%3A%20A,pocket%20costs%20for%20consumers%2C%20and."},{"key":"10.1016\/j.hpopen.2026.100163_b0015","unstructured":"DHHHS. American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs 2018."},{"key":"10.1016\/j.hpopen.2026.100163_b0020","unstructured":"CMS. Modernizing Part D and Medicare Advantage To Lower Drug Prices and Reduce Out-of-Pocket Expenses. Federal Register2019."},{"key":"10.1016\/j.hpopen.2026.100163_b0025","unstructured":"Kona SCM. CHIRblog [Internet]: Center on Health Insurance Reforms. 2023. [cited 2023 11\/01\/2023]. Available from: https:\/\/chirblog.org\/can-employer-sponsored-insurance-be-saved-a-review-of-policy-options-price-transparency\/."},{"key":"10.1016\/j.hpopen.2026.100163_b0030","unstructured":"NCI. Annual Report to the Nation 2021: Special Topic: Patient Economic Burden of Cancer Care2021 10\/06\/2022. Available from: https:\/\/seer.cancer.gov\/report_to_nation\/special.html#site."},{"issue":"4","key":"10.1016\/j.hpopen.2026.100163_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.hpopen.2026.100163_b0040","first-page":"45","article-title":"How patient cost-sharing trends affect adherence and outcomes: a literature review","volume":"37","author":"Eaddy","year":"2012","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.hpopen.2026.100163_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.298.1.61","article-title":"Prescription drug cost sharing: associations with medication and medical utilization and spending and health","volume":"298","author":"Goldman","year":"2007","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.hpopen.2026.100163_b0050","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030635","article-title":"Treatment of advanced prostate cancer-a review of current therapies and future promise","volume":"8","author":"Sumanasuriya","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.hpopen.2026.100163_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of advanced prostate cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.hpopen.2026.100163_b0060","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1200\/OP.22.00645","article-title":"Medication payments by insurers and patients for the treatment of metastatic castrate-resistant prostate cancer","volume":"19","author":"Kaye","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.hpopen.2026.100163_b0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0081175019852763","article-title":"A general framework for comparing predictions and marginal effects across models","volume":"49","author":"Mize","year":"2019","journal-title":"Sociol Methodol"},{"issue":"4","key":"10.1016\/j.hpopen.2026.100163_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/UPJ.0000000000000020","article-title":"Patient and provider variables associated with variation in the systemic treatment of advanced prostate cancer","volume":"6","author":"Caram","year":"2019","journal-title":"Urol Pract"}],"container-title":["Health Policy OPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590229626000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590229626000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:42:30Z","timestamp":1781077350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590229626000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":14,"alternative-id":["S2590229626000031"],"URL":"https:\/\/doi.org\/10.1016\/j.hpopen.2026.100163","relation":{},"ISSN":["2590-2296"],"issn-type":[{"value":"2590-2296","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Price transparency & out-of-pocket payments for medications: Implications of associated delivery fees in the United States","name":"articletitle","label":"Article Title"},{"value":"Health Policy OPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpopen.2026.100163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100163"}}